Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma

European Journal of Endocrinology

Volumn 166, Issue 2, 2012, Pages 241-245

  Barbieri, R B ^a   Bufalo, N E ^a   Secolin, R ^a   Silva, A C N ^a   Assumpcao L V M ^a   Maciel, R M B ^b   Cerutti, J M ^b   Ward, L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL CYCLE REGULATION; CLINICAL FEATURE; CODON; CONTROLLED STUDY; CYP1A1M1 GENE; CYP1A2 GENE; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GSTP1 GENE; HUMAN; MALE; NAT2 GENE; NAT2C GENE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID MEDULLARY CARCINOMA; TUMOR DIFFERENTIATION; TUMOR GENE;

ADULT; ALCOHOL DRINKING; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84856106725     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0843     Document Type: Article

References (20)

1. Aschebrook-Kilfoy B, Ward MH, Sabra MM & Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 2011 21 125-134. (doi:10.1089/thy.2010. 0021)
2. Kebebew E, Ituarte PH, Siperstein AE, Duh QY & Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000 88 1139-1148. (doi:10.1002/(SICI) 1097-0142(20000 301)88:5〈1139::AID-CNCR26〉3.0.CO;2-Z)
3. Romei C, Cosci B, Renzini G, Bottici V, Molinaro E, Agate L, Passannanti P, Viola D, Biagini A, Basolo F, Ugolini C, Materazzi G, Pinchera A, Vitti P & Elisei R. RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). Clinical Endocrinology 2011 74 241-247. (doi:10.1111/j.1365-2265.2010.03900.x)
4. Elisei R, Cosci B, Romei C, Bottici V, Sculli M, Lari R, Barale R, Pacini F & Pinchera A. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. Journal of Clinical Endocrinology and Metabolism 2004 89 3579-3584. (doi:10. 1210/jc.2003-031898)
5. Tamanaha R, Camacho CP, Pereira AC, da Silva AM, Maciel RM & Cerutti JM. Evaluation of RET polymorphisms in a six-generation family with G533C RET mutation: specific RET variants may modulate age at onset and clinical presentation. Clinical Endocrinology 2009 71 56-64. (doi:10.1111/j.1365-2265. 2008.03491.x)
6. Wiench M, Wygoda Z, Gubala E, Wloch J, Lisowska K, Krassowski J, Scieglinska D, Fiszer-Kierzkowska A, Lange D, Kula D, Zeman M, Roskosz J, Kukulska A, Krawczyk Z & Jarzab B. Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients. Journal of Clinical Oncology 2001 19 1374-1380. (Pubitemid 32202543)
7. Pasquali D, Circelli L, Faggiano A, Pancione M, Renzullo A, Elisei R, Romei C, Accardo G, Coppola VR, De Palma M, Ferolla P, Grimaldi F, Colao A & Colantuoni V. CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma. European Journal of Endocrinology 2011 164 397-404. (doi:10.1530/EJE-10-0929)
8. Bufalo NE, Leite JL, Guilhen AC, Morari EC, Granja F, Assumpcao LV & Ward LS. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants. Endocrine-Related Cancer 2006 13 1185-1193. (doi:10.1677/ ERC-06-0002)
9. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV & Ward LS. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Letters 2004 210 151- 157. (doi:10.1016/j.canlet.2004.01. 016)
10. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV & Ward LS. GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Letters 2004 209 129-137. (doi:10. 1016/j.canlet.2003.12.013)
11. Guilhen AC, Bufalo NE, Morari EC, Leite JL, Assumpcao LV, Tincani AJ & Ward LS. Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility. Clinical Cancer Research 2009 15 406-412. (doi:10.1158/1078-0432. CCR-08-1835)
12. Ward LS, Morari EC, Leite JL, Bufalo NE, Guilhen AC, Araujo PP, Tincani AJ, Assumpcao LV & Matos PS. Identifying a risk profile for thyroid cancer. Arquivos Brasileiros de Endocrinologia e Metabologia 2007 51 713-722. (doi:10.1590/S0004-2730 2007000500008)
13. Hothorn T & Leisch F. Case studies in reproducibility. Briefings in Bioinformatics 2011 12 288-300. (doi:10.1093/bib/bbq084)
14. Excoffier L & Lischer HE. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Molecular Ecology Resources 2010 10 564-567. (doi:10.1111/j.1755-0998.2010. 02847.x)
15. Faul F, Erdfelder E, Lang AG & Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007 39 175-191. (doi:10.3758/BF03193146)
16. Giolo SR, Soler JM, Greenway SC, Almeida MA, de Andrade M, Seidman JG, Seidman CE, Krieger JE & Pereira AC. Brazilian urban population genetic structure reveals a high degree of admixture. European Journal of Human Genetics 2012. (doi:10.1038/ejhg. 2011.144)
17. Pruss-Ustun A & Corvalan C. How much disease burden can be prevented by environmental interventions? Epidemiology 2007 18 167-178. (doi:10.1097/01.ede.0000239647.26389.80)
18. Agundez JA. Polymorphisms of human N-acetyltransferases and cancer risk. Current Drug Metabolism 2008 9 520-531. (doi:10. 2174/138920008784892083)
19. Loktionov A. Common gene polymorphisms, cancer progression and prognosis. Cancer Letters 2004 208 1-33. (doi:10.1016/j.canlet.2004.02.009)
20. Gra O, Mityaeva O, Berdichevets I, Kozhekbaeva Z, Fesenko D, Kurbatova O, Goldenkova-Pavlova I & Nasedkina T. Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians. Genetic Testing and Molecular Biomarkers 2010 14 329-342. (doi:10.1089/gtmb.2009.0158)